Adma Biologics reported $0.19 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.21 0.15 Nov/11
0.16 0.18 0.14 Aug/05
FY2027Q1 Mar/2026 0.19 0.19 0.12 May/06




Eps Change Date
Adma Biologics USD 0.19 0.01 Mar/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Takeda JPY 71.65 87.21 Jun/2026